相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genetic polymorphisms and multiple myeloma risk: a meta-analysis
Pengcheng Zhang et al.
ANNALS OF HEMATOLOGY (2020)
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
Szymon Zmorzynski et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Haematology: multiple myeloma
John Firth
CLINICAL MEDICINE (2019)
Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma
H. Haydaroglu et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival
Kaspar Rene Nielsen et al.
LEUKEMIA & LYMPHOMA (2017)
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma
Ming Han et al.
BLOOD (2016)
Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses
Theodoros N. Sergentanis et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations-An Extensive Replication of the Associations from the Candidate Gene Era
Alessandro Martino et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
In silico analysis of single nucleotide polymorphism (SNP) in human TNF-α gene
Brijesh Dabhi et al.
META GENE (2014)
Lack of association between TNF-α promoter polymorphisms and multiple myeloma: A meta-analysis
Bing Li et al.
LEUKEMIA RESEARCH (2013)
TNF alpha Mediated IL-6 Secretion Is Regulated by JAK/STAT Pathway but Not by MEK Phosphorylation and AKT Phosphorylation in U266 Multiple Myeloma Cells
Chansu Lee et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Genetic variations in multiple myeloma I: effect on risk of multiple myeloma
Annette Vangsted et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?
Alessandro Martino et al.
LEUKEMIA RESEARCH (2012)
Tumour Necrosis Factor Gene Polymorphism and Disease Prevalence
T. Qidwai et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha
L. J. ABRAHAM et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line
Magne Börset et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone
Juan Du et al.
LEUKEMIA RESEARCH (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma
Katalin Kadar et al.
LEUKEMIA RESEARCH (2008)
Common variants in genes that mediate immunity and risk of multiple myeloma
Elizabeth E. Brown et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Multiple myeloma: A review of the epidemiologic literature
Dominik D. Alexander et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cytokine gene polymorphisms, cancer susceptibility, and prognosis
W. Martin Howell et al.
JOURNAL OF NUTRITION (2007)
Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population
W. Y. Au et al.
LEUKEMIA & LYMPHOMA (2006)
Haplotypes in the tumour necrosis factor region and myeloma
GJ Morgan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Molecular genetic analysis of the interleukin 6 and tumor necrosis factor α gene polymorphisms in multiple myeloma
EV Yakupova et al.
MOLECULAR BIOLOGY (2003)
Cytokine gene polymorphism in human disease: on-line databases, Supplement 2
N Haukim et al.
GENES AND IMMUNITY (2002)
Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta(2)-microglobulin, and clinical stage in multiple myeloma
V Jurisic et al.
MEDICAL ONCOLOGY (2002)
The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma:: therapeutic applications
T Hideshima et al.
ONCOGENE (2001)
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
FE Davies et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Interleulkin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma
CY Zheng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)